SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-24-048398
Filing Date
2024-04-17
Accepted
2024-04-17 17:22:57
Documents
18
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A tm2411648d3_10ka.htm   iXBRL 10-K/A 373908
2 EXHIBIT 31.1 tm2411648d3_ex31-1.htm EX-31.1 3654
3 EXHIBIT 31.2 tm2411648d3_ex31-2.htm EX-31.2 3440
8 GRAPHIC tm2411648d3_img001.jpg GRAPHIC 72838
9 GRAPHIC tm2411648d3_img002.jpg GRAPHIC 80827
  Complete submission text file 0001104659-24-048398.txt   1082709

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA jagx-20231231.xsd EX-101.SCH 3552
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE jagx-20231231_def.xml EX-101.DEF 28813
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE jagx-20231231_lab.xml EX-101.LAB 39215
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE jagx-20231231_pre.xml EX-101.PRE 27422
22 EXTRACTED XBRL INSTANCE DOCUMENT tm2411648d3_10ka_htm.xml XML 7386
Mailing Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104
Business Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104 415-371-8300
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36714 | Film No.: 24852057
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)